# IL-40 and IL-41 Levels in Sepsis, Septic Shock, and Healthy Individuals

> **NCT06963541** · — · NOT_YET_RECRUITING · sponsor: **Melahat Yalcin Solak** · enrollment: 80 (estimated)

## Conditions studied

- Sepsis
- Septic Shock
- Inflammation
- Biomarkers

## Interventions

- **OTHER:** No intervention; Observational study

## Key facts

- **NCT ID:** NCT06963541
- **Lead sponsor:** Melahat Yalcin Solak
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-15
- **Primary completion:** 2025-11-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06963541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06963541, "IL-40 and IL-41 Levels in Sepsis, Septic Shock, and Healthy Individuals". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06963541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*